Alcoholic Cirrhosis Symptoms Stages and Treatment

Alcoholic cirrhosis is advanced, alcohol-related liver scarring, and while the damage is largely permanent, stopping drinking and getting proper treatment can still add years to survival.

Jessica Miller is the Content Manager of Addiction HelpWritten by
Kent S. Hoffman, D.O. is a founder of Addiction HelpMedically reviewed by Kent S. Hoffman, D.O.
Last updated

Battling addiction & ready for help?

Find Treatment Now

A Cirrhosis Diagnosis Is Not the End

Alcoholic cirrhosis is the most advanced stage of alcohol-related liver disease, the point where years of heavy drinking leave the liver so scarred that it can no longer filter blood, make essential proteins, or clear toxins the way it should.

Hearing this diagnosis feels like a door closing, but the data tell a more hopeful story: abstinence from alcohol is strongly associated with a better trajectory, even in advanced disease, with continued drinking linked to markedly worse decompensation and survival outcomes[1].

Certain symptoms mean emergency care now. Confusion, vomiting blood, or sudden belly swelling are decompensation, not something to sleep off.
Vomiting blood, sudden confusion, or extreme drowsiness can mean variceal bleeding or hepatic encephalopathy—call 911 or get to an ER immediately. If drinking feels impossible to stop safely on your own, call or text 988 or ask a doctor about supervised medical detox rather than stopping alone; withdrawal from heavy long-term drinking can itself be dangerous.

How Common Is Alcohol-Related Cirrhosis?

Alcohol is the single biggest driver of cirrhosis deaths, both in the US and worldwide. It causes an estimated 40 to 50% of all US cirrhosis deaths, and the toll keeps climbing.

  • In the US, alcohol drives 40–50% of all cirrhosis deaths and accounts for about 30% of liver transplants[2]
  • In Europe, alcohol-related liver disease accounts for closer to 50% of liver transplants[2]
  • Globally, 45–60% of cirrhosis deaths trace back to alcohol, and these numbers have not been improving[2]
AddictionHelp.com Fast Facts
  • Decompensated cirrhosis plus continued drinking: about 22.9% five-year survival; with abstinence, that jumps to 73.8%[1]
  • Alcohol causes 40–50% of U.S. cirrhosis deaths and about 30% of U.S. liver transplants[2]
  • Ascites is the single most common complication, affecting 43.5% of patients in one large cohort
  • Only 14% of veterans diagnosed with alcohol use disorder and cirrhosis received any AUD treatment within 180 days[3]

How Cirrhosis Develops

The liver tolerates a remarkable amount of alcohol-related injury before cirrhosis takes hold. Damage builds over a span that can run 5 to 40 years, with the pace influenced by genetic factors and other associated risk factors[2].

The Three-Phase Cascade

  • Fatty liver (steatosis): fat accumulates inside liver cells
  • Inflammation (steatohepatitis): immune signals trigger early cell death
  • Scarring (fibrosis to cirrhosis): collagen stiffens and replaces healthy tissue

Why Pressure Builds Up

Alcohol and its byproducts trigger immune cells to release inflammatory signals, which activate hepatic stellate cells. These cells start producing collagen that stiffens the liver’s internal structure. As scarring advances it compresses blood vessels and raises portal hypertension, the pressure buildup behind almost every major complication of cirrhosis.

Did you know?

Early-stage fibrosis is not a permanent sentence. If drinking stops soon enough, the liver can partially remodel and clear away some of that scar tissue on its own.

Liver Cirrhosis Stages Explained

Stage What’s Happening Can It Reverse?
Steatosis (fatty liver) Fat accumulates in liver cells from alcohol processing Yes, often within weeks of abstinence
Steatohepatitis Inflammation and early cell death begin Largely yes, with sustained abstinence
Fibrosis Collagen scar tissue starts replacing healthy tissue Partially, in early stages, with abstinence
Compensated cirrhosis Liver is scarred but still performs its jobs Scarring itself is largely permanent; progression can stop
Decompensated cirrhosis First major complication appears (ascites, bleeding, confusion, kidney failure) Not reversible; treatment focuses on stabilizing and preventing further events

Compensated vs Decompensated Cirrhosis

The line between these two states is the single biggest factor in what happens next.

Compensated Cirrhosis

Compensated cirrhosis can look like nothing is wrong. The liver is scarred but still handles clotting, protein production, and toxin clearance, so many people feel well and go years, sometimes over a decade, without a major event, especially if they stop drinking. Among abstinent people with compensated cirrhosis, five-year survival reaches 90.7%, versus 45.9% for those who keep drinking[1].

Decompensated Cirrhosis

Decompensated cirrhosis is defined by the arrival of the first serious complication, such as ascites, variceal bleeding, hepatic encephalopathy, or kidney failure, and from that point the prognostic clock moves faster. Continued drinking after decompensation drops five-year survival to about 22.9%, while abstinence lifts it to 73.8%[1].

Group Abstinent 5-Year Survival Continued Drinking 5-Year Survival
Compensated cirrhosis 90.7% 45.9%
Decompensated cirrhosis 73.8% 22.9%

Symptoms and Nail Clues

Early cirrhosis often hides behind fatigue, mild appetite loss, or no symptoms at all, which is part of why it can go undiagnosed for years. As the liver struggles more, more visible signs appear, including changes clinicians look for in the hands and nails.

Compensated / Early Signs Decompensated / Advanced Signs
Fatigue, low energy Yellowing of skin and eyes (jaundice)
Mild loss of appetite Swollen belly from fluid buildup (ascites)
Often no symptoms at all Confusion, personality change, drowsiness
Spider-like blood vessels on skin Vomiting blood or black stools
Nail and skin changes beginning Terry’s nails, finger clubbing, leukonychia (white nail bands)

What the Nail Changes Mean

These nail findings (Terry’s nails, clubbing, and leukonychia) reflect the same underlying problem: a liver that can no longer make enough albumin or clear toxins normally. They are useful clues but never the whole picture, and any of these advanced signs deserves prompt medical evaluation.

Complications That Signal Danger

Each major complication below stems from the same root cause, portal hypertension, but each is treated differently and each marks a real shift in how urgently care is needed.

Ascites

Ascites, fluid collecting in the abdomen, is the most common complication of cirrhosis, showing up in 43.5% of patients in one large cohort.

Treatment escalates in steps:
– Sodium restriction plus diuretics, first-line
– Paracentesis (draining fluid directly) with albumin support when fluid becomes stubborn
– TIPS shunt to relieve pressure at its source

A related danger, spontaneous bacterial peritonitis, is an infection of that fluid requiring urgent antibiotics and albumin, and it marks a point where transplant evaluation should be revisited without delay.

Variceal Bleeding

Rising pressure pushes blood into fragile veins in the esophagus and stomach called varices, which can rupture and bleed catastrophically. People with cirrhosis are screened by endoscopy, and those with medium-to-large varices are typically started on beta-blockers or treated with band ligation before any bleeding happens. Active bleeding is an emergency treated with medication, urgent endoscopy, and antibiotics, since infection often triggers or follows a bleed.

Hepatic Encephalopathy

Hepatic encephalopathy ranges from subtle memory and concentration problems to full confusion or coma, driven by ammonia the failing liver can no longer clear. Lactulose is the backbone treatment, with rifaximin added to prevent repeat episodes; most flare-ups have a fixable trigger like infection, dehydration, or constipation. Problematic drinking is associated with worse quality of life in these same memory and health-distress domains, even after accounting for liver disease severity scores[4].

Hepatorenal Syndrome

Hepatorenal syndrome is kidney failure caused by the liver’s circulatory chaos rather than direct kidney damage, and its acute form can progress quickly. Treatment combines vasoconstrictor medication with albumin, but transplant is the only definitive fix, and its appearance should prompt urgent transplant reassessment.

Life Expectancy and Prognosis

MELD and Child-Pugh Scores

Two scoring tools drive most prognosis conversations.

  • MELD-Na predicts short-term survival and sets transplant waitlist priority; higher numbers mean greater urgency
  • Child-Pugh score classifies severity as A (compensated) through C (decompensated) and was itself a strong independent predictor of death in one large cohort (hazard ratio 4.453)[1]
  • Muscle wasting, or sarcopenia, adds further prognostic weight beyond either score

Why Abstinence Timing Matters

The abstinence timeline matters more than most people expect. Continued drinking independently predicted death with a hazard ratio of 3.371, but the survival benefit of quitting only became fully apparent after at least two years of sustained abstinence[1]. Short-term sobriety helps, but the full protective effect takes sustained commitment to show up.

Did you know?

A single Child-Pugh score was found to predict mortality more strongly than several other markers combined in one large cirrhosis cohort, severity classification still carries real weight in modern prognosis.

Is Liver Damage Reversible?

Scar tissue itself does not fully disappear once cirrhosis is established, but that is not the same as saying nothing can be done. Stopping alcohol removes the ongoing source of liver injury, which is a critical goal of treatment even though achieving abstinence is often difficult[2].

Even in advanced disease, abstinence is the single intervention most likely to change what happens next, often more than any medication or procedure alone.

Alcoholic Cirrhosis Treatment Options

Treating the Alcohol Use Disorder

The biggest gap in care for this disease is not medical complexity, it is access.

  • Only 14% of veterans with cirrhosis and AUD received any AUD treatment within 180 days of diagnosis[3]
  • Only 32% of patients in a separate multicenter study reported using AUD treatment in the past year[5]
  • Among people referred to addiction care, only 35% ever established that care[6]
  • Treating the AUD pays off directly: a 37% reduction in new liver decompensation and a meaningful drop in long-term mortality among veterans who received it[3]
  • Simply identifying AUD during a hospital stay cut 30-day readmission odds by 15%[7]

This is largely a systems failure, not a motivation failure.

Medication Choices

Medication Use In Cirrhosis Key Consideration
Baclofen Strongest evidence base for cirrhotic patients; preferred in advanced disease Renally cleared, no hepatotoxicity concern, but overall evidence base is still small[8][9]
Acamprosate Generally safer in liver disease Renally cleared; needs dose adjustment if kidneys are also impaired
Naltrexone Use with caution, monitor liver enzymes Known hepatotoxicity risk; cirrhosis-specific safety data are limited
Did you know?

Baclofen is the only medication shown in a randomized trial to significantly improve abstinence specifically in people with cirrhosis, with odds more than six times higher than comparison groups[8].

Behavioral and psychological therapies are used in cirrhotic patients, though the evidence so far is mixed and underpowered rather than clearly negative[8]. Co-occurring anxiety or depression is linked to higher rates of engaging with AUD treatment in one cohort of disadvantaged patients[5], which argues for screening mental health alongside liver health.

Liver Transplant Path

When Transplant Is Considered

Liver transplantation is the definitive treatment for decompensated alcoholic cirrhosis that no longer responds to medical management, and it may also be considered for severe alcoholic hepatitis that doesn’t respond to medication[10][11]. In the U.S., listing typically begins once MELD-Na reaches 15 or higher, with higher scores prioritized on the waitlist.

The Sobriety Requirement

Many centers have historically required six months of documented sobriety before listing, intended to allow spontaneous recovery and gauge relapse risk. That threshold is a convention rather than a proven predictor, and some centers now offer earlier transplant to carefully screened patients with severe alcoholic hepatitis who don’t respond to standard treatment.

Portal Hypertension, Explained SimplyThink of it as a traffic jam. Scar tissue blocks blood flow through the liver, so pressure backs up into the veins of the gut, spleen, and esophagus, forcing fluid and blood into places it shouldn’t be.

Centers use structured tools like SIPAT and the SALT score to assess candidacy, weighing social support and AUD severity alongside liver numbers.

The Access Gap

Only 28.1% of cirrhotic patients in one cohort even underwent pre-transplant evaluation, echoing the same treatment gaps seen in AUD care.

Liver Cirrhosis Diet

Diet changes are one of the more manageable levers a person with cirrhosis controls day to day. Sodium restriction, typically under 2 grams per day, is standard first-line management for fluid buildup and ascites, usually paired with diuretics.

RememberCompensated doesn’t mean cured. It means the liver is still coping, and what you do next largely determines whether it stays that way.

Because muscle wasting and frailty independently worsen outcomes and complicate transplant candidacy, adequate protein and calorie intake matter as much as sodium limits, and a dietitian familiar with liver disease can help balance both without overloading sodium.

Alcoholic Cirrhosis ICD-10 Codes

Clinicians and billing records typically use the following codes to document alcoholic cirrhosis and its complications.

Code Description
K70.30 Alcoholic cirrhosis of liver, without ascites
K70.31 Alcoholic cirrhosis of liver, with ascites
K70.9 Alcoholic liver disease, unspecified

Getting Help Now

None of these numbers are meant to suggest that the outcome is fixed. The same research shows that in a large retrospective cohort, identifying alcohol use disorder in a hospital setting was associated with lower 30-day readmission for patients with alcohol-associated cirrhosis, though the authors caution this does not establish causation[7]. The gap between what’s possible and what people currently receive is largely about access, not hopelessness.

If you or someone you love is facing alcoholic cirrhosis, connect with treatment options built for co-occurring liver disease and alcohol use disorder.

Frequently asked questions

What Is Alcoholic Cirrhosis?

It is the most advanced stage of alcohol-related liver disease, where years of heavy drinking cause permanent scarring that keeps the liver from working normally[2].

What Are The Stages Of Alcoholic Cirrhosis?

Liver damage typically moves from fatty liver to inflammation to fibrosis to compensated cirrhosis and finally decompensated cirrhosis, a process that can take 5 to 40 years[2].

Can Alcoholic Cirrhosis Be Reversed?

Abstinence is critical to ALD management, and treatment is far less effective without it[2].

What Is The Life Expectancy With Alcoholic Cirrhosis?

It depends heavily on drinking status. In one large study, five-year survival with decompensated cirrhosis was about 22.9% for those who kept drinking versus 73.8% for those who became abstinent; across all patients it was 32.2% versus 82.4%[1].

Do Nail Changes Really Signal Liver Disease?

Yes, Terry’s nails, clubbing, and leukonychia are recognized signs linked to low albumin and advanced liver dysfunction, though they always need to be confirmed alongside other findings.

When Is A Liver Transplant Needed?

Transplant is considered the definitive treatment for advanced alcoholic cirrhosis once decompensation no longer responds to medical management[10].

Get Treatment Help

If you or someone you love is struggling with addiction, getting help is just a phone call away, or consider trying therapy online with BetterHelp.

Exclusive offer: 20% Off BetterHelp*

Following links to the BetterHelp website may earn us a commission that helps us manage and maintain AddictionHelp.com. *Get 20% off your first month of BetterHelp. Offer valid for new BetterHelp users only. Offer cannot be combined with insurance.

11 Sources
  1. Kalambokis, G. N., Chouliara, N., Tsiakas, I., Filippas-Ntekuan, S., Christaki, M., Despotis, G., & Milionis, H. (2024). Impact of continued alcohol use on liver-related outcomes of alcohol-associated cirrhosis: a retrospective study of 440 patients. European journal of gastroenterology & hepatology.
  2. Testino, G., Leone, S., & Borro, P. (2016). Treatment of alcohol use disorder patients affected by liver cirrhosis and/or hepatocellular carcinoma awaiting liver transplantation. Minerva medica.
  3. Rogal, S., Youk, A., Zhang, H., Gellad, W. F., Fine, M. J., Good, C. B., Chartier, M., DiMartini, A., Morgan, T., Bataller, R., & Kraemer, K. L. (2020). Impact of Alcohol Use Disorder Treatment on Clinical Outcomes Among Patients With Cirrhosis. Hepatology.
  4. Luk, J. W., Satre, D. D., Cheung, R., Wong, R. J., Monto, A., Chen, J. Y., Batki, S. L., Ostacher, M. J., Snyder, H. R., Shui, A. M., Liao, M., Haight, C. G., & Khalili, M. (2024). Problematic alcohol use and its impact on liver disease quality of life in a multicenter study of patients with cirrhosis. Hepatol Commun.
  5. Luk, J. W., Ha, N. B., Shui, A. M., Snyder, H. R., Batki, S. L., Ostacher, M. J., Monto, A., Wong, R. J., Cheung, R., Parekh, P., Hua, W., Tompkins, D. A., Fakadej, T., Haight, C. G., Liao, M., Khalili, M., & Satre, D. D. (2025). Demographic and clinical characteristics associated with utilization of alcohol use disorder treatment in a multicenter study of patients with alcohol-associated cirrhosis. Alcohol Clin Exp Res.
  6. Haque, L. Y., Jakab, S., Deng, Y., Ciarleglio, M. M., & Tetrault, J. M. (2020). Substance Use Disorders in Recently Hospitalized Patients With Cirrhosis. J Addict Med.
  7. Singal, A. K., DiMartini, A., Leggio, L., Arab, J. P., Kuo, Y., & Shah, V. H. (2022). Identifying Alcohol Use Disorder in Patients With Cirrhosis Reduces 30-Days Readmission Rate. Alcohol Alcohol.
  8. Oldroyd, C., Greenham, O., Martin, G., Allison, M., & Notley, C. (2023). Systematic review: Interventions for alcohol use disorder in patients with cirrhosis or alcohol-associated hepatitis. Aliment Pharmacol Ther.
  9. Addolorato, G., Russell, M., Albano, E., Haber, P. S., Wands, J. R., & Leggio, L. (2009). Understanding and treating patients with alcoholic cirrhosis: an update. Alcoholism, clinical and experimental research.
  10. Ashwani K Singal, Ramon Bataller, Joseph Ahn, Patrick S Kamath, & Vijay H Shah (2018). ACG Clinical Guideline: Alcoholic Liver Disease. The American journal of gastroenterology.
  11. Velarde-Ruiz Velasco, J. A., Higuera-de la Tijera, M. F., Castro-Narro, G. E., Zamarripa-Dorsey, F., Abdo-Francis, J. M., Aiza Haddad, I., Aldana Ledesma, J. M., Bielsa-Fernández, M. V., Cerda-Reyes, E., Cisneros-Garza, L. E., Contreras-Omaña, R., Reyes-Dorantes, A., Fernández-Pérez, N. J., García-Jiménez, E. S., Icaza-Chávez, M. E., Kershenobich-Stalnikowitz, D., Lira-Pedrín, M. A., Moreno-Alcántar, R., Pérez-Hernández, J. L.,… Torre-Delgadillo, A. (2020). The Mexican consensus on alcoholic hepatitis. Revista de gastroenterologia de Mexico.
Written by
Jessica Miller is the Content Manager of Addiction Help

Editorial Director

Jessica Miller is the Editorial Director of Addiction Help. Jessica graduated from the University of South Florida (USF) with an English degree and combines her writing expertise and passion for helping others to deliver reliable information to those impacted by addiction. Informed by her personal journey to recovery and support of loved ones in sobriety, Jessica's empathetic and authentic approach resonates deeply with the Addiction Help community.

Reviewed by
  • Fact-Checked
  • Editor
Kent S. Hoffman, D.O. is a founder of Addiction Help

Co-Founder & Chief Medical Officer

Kent S. Hoffman, D.O. has been an expert in addiction medicine for more than 15 years. In addition to managing a successful family medical practice, Dr. Hoffman is board certified in addiction medicine by the American Osteopathic Academy of Addiction Medicine (AOAAM). Dr. Hoffman has successfully treated hundreds of patients battling addiction. Dr. Hoffman is the Co-Founder and Chief Medical Officer of AddictionHelp.com and ensures the website’s medical content and messaging quality.

Real Help. Real Recovery.

Compare centers, explore options and start your path to recovery today.

Find Treatment Now

"AddictionHelp.com is helping to make recovery available to EVERYONE!"

- Angela N.